Passa al contenuto
Merck

Integrator endonuclease drives promoter-proximal termination at all RNA polymerase II-transcribed loci.

Molecular cell (2022-10-30)
Chad B Stein, Andrew R Field, Claudia A Mimoso, ChenCheng Zhao, Kai-Lieh Huang, Eric J Wagner, Karen Adelman
ABSTRACT

RNA polymerase II (RNAPII) pausing in early elongation is critical for gene regulation. Paused RNAPII can be released into productive elongation by the kinase P-TEFb or targeted for premature termination by the Integrator complex. Integrator comprises endonuclease and phosphatase activities, driving termination by cleavage of nascent RNA and removal of stimulatory phosphorylation. We generated a degron system for rapid Integrator endonuclease (INTS11) depletion to probe the direct consequences of Integrator-mediated RNA cleavage. Degradation of INTS11 elicits nearly universal increases in active early elongation complexes. However, these RNAPII complexes fail to achieve optimal elongation rates and exhibit persistent Integrator phosphatase activity. Thus, only short transcripts are significantly upregulated following INTS11 loss, including transcription factors, signaling regulators, and non-coding RNAs. We propose a uniform molecular function for INTS11 across all RNAPII-transcribed loci, with differential effects on particular genes, pathways, or RNA biotypes reflective of transcript lengths rather than specificity of Integrator activity.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Cocktail di inibitori delle fosfatasi 2, aqueous solution (dark coloration may develop upon storage, which does not affect the activity)
Sigma-Aldrich
Cocktail di inibitori delle fosfatasi 3, DMSO solution
Sigma-Aldrich
Anticorpo anti-RNA polimerasi II, subunità B1 (fosfo CTD Ser-2), clone 3E10, clone 3E10, from rat
Sigma-Aldrich
Anti-INTS11 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution